Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pathology-genomic fusion via biologically informed cross-modality graph learning for survival analysis.

Created on 08 Aug 2026

Authors

Zeyu Zhang, Yuanshen Zhao, Jingxian Duan, Yaou Liu, Hairong Zheng, Dong Liang, Zhenyu Zhang, Zhi-Cheng Li

Published in

IEEE journal of biomedical and health informatics. Volume PP. Aug 07, 2026. Epub Aug 07, 2026.

Abstract

Accurate cancer survival prediction remains challenging due to tumor heterogeneity. While multi-modal data integration-particularly histopathology images and genomics-holds promise, effective fusion is hindered by biological complexity, gene detection variability, and limited cross-modal interpretability. To address this, we propose SurvPAGE, a Survival prediction model by fusing PAthological whole-slide images and RNA sequencing GEnomic data via biologically informed heterogeneous graph learning framework. SurvPAGE constructs modality-specific graphs encoding spatial histology patterns and functional genomic pathway interactions, connected by inter-modal edges modeling genotype-phenotype relationships. We introduce genGraphMAE, a masked graph autoencoder enhancing robustness against gene detection variability by reconstructing both pathway features and interactions from partially masked gene inputs. Attention-based graph learning dynamically fuses intra- and inter-modal contexts, while integrated gradients and attention heatmaps provide multi-scale interpretability, identifying prognostic histology regions and driver genes. Evaluated on lower-grade glioma, glioblastoma, and renal carcinoma datasets from TCGA and a local hospital, SurvPAGE achieves state-of-the-art performance in terms of C-index over existing multimodal benchmarks in survival prediction and reveals potential prognostic gene markers. This work improves cancer prognosis prediction by fusing pathology and genomic data through biologically informed interpretable graph learning.

PMID:
42566373
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement